Leptomeningeal Metastasis from Non-small Cell Lung Cancer: Survival and the Impact of Whole Brain Radiotherapy
- 29 February 2012
- journal article
- Published by Elsevier BV in Journal of Thoracic Oncology
- Vol. 7 (2), 382-385
- https://doi.org/10.1097/jto.0b013e3182398e4f
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancerJournal of Neuro-Oncology, 2010
- Leptomeningeal metastases in the MRI eraNeurology, 2010
- Efficacy of Erlotinib for Brain and Leptomeningeal Metastases in Patients with Lung Adenocarcinoma Who Showed Initial Good Response to GefitinibJournal of Thoracic Oncology, 2009
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary AdenocarcinomaNew England Journal of Medicine, 2009
- Patterns of palliative procedures and clinical outcomes in patients with advanced non-small cell lung cancerLung Cancer, 2009
- Leptomeningeal and Medullary Response to Second-Line Erlotinib in Lung AdenocarcinomaJournal of Thoracic Oncology, 2008
- Erlotinib in Previously Treated Non–Small-Cell Lung CancerNew England Journal of Medicine, 2005
- Ventriculoperitoneal shunt in patients with leptomeningeal metastasisNeurology, 2005
- High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinibCancer, 2005
- Pilot Trial of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Gefitinib Plus Carboplatin and Paclitaxel in Patients With Stage IIIB or IV Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2003